T48.0X5
Adverse effect of oxytocic drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
Oxytocic drugs are medications used to stimulate uterine contractions, commonly administered during labor to assist delivery or manage postpartum bleeding. While these drugs are effective in facilitating childbirth, they can sometimes cause adverse effects. The ICD-10 code T48.0X5 specifically relates to adverse effects resulting from the use of oxytocic drugs, highlighting the importance of careful monitoring and management during their administration.
Causes & Symptoms
Clinical Causes: Excessive dosage of oxytocic medications Sensitivity or allergic reactions to the drug Incorrect administration technique or timing Interaction with other medications that affect uterine activity Pre-existing medical conditions that increase risk Prolonged use beyond recommended duration
Key Symptoms: Intense or abnormal uterine contractions Uterine hyperstimulation, leading to fetal distress Uterine rupture or tearing Placental abruption Excessive bleeding (hemorrhage) Nausea and vomiting Fever or signs of infection Changes in fetal heart rate patterns Pain in the abdomen or pelvic area
Diagnostic & Treatment
Diagnosis Path: Identifying adverse effects related to oxytocic drugs typically involves a comprehensive clinical evaluation. Healthcare professionals review the patient's medication history, administer physical examinations, and monitor uterine activity and fetal well-being. Additional diagnostic procedures like ultrasound imaging may be used to assess uterine integrity or detect complications such as rupture or placental issues. Laboratory tests can aid in ruling out other causes of symptoms such as infection or bleeding.
Treatment Protocols: Managing adverse effects from oxytocic drugs requires prompt medical attention. Depending on the severity, treatments may include:
Clinical Advice & FAQs
Billing Guidance
Is T48.0X5 a billable ICD-10 code?
Yes, T48.0X5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T48.0X5?
Clinical documentation must specify the nature of Adverse effect of oxytocic drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference